Generate a tailored SOP for Dr. Arielle Elkrief. Improve your application with a focused, well-structured draft.
Arielle Elkrief is a clinician-scientist with a focus on gut tumor microbiome interactions and their response to immunotherapy. As an Assistant Professor in the Department of Oncology at the Centre hospitalier de l’Université de Montréal (CHUM), she co-directs the CHUM Microbiome Centre. Her research includes leading microbiome-centered clinical trials and investigating the role of antibiotics on immunotherapy efficacy in cancer patients. Dr. Elkrief has published over 74 papers in prestigious journals such as the Journal of Clinical Oncology and Nature Medicine, contributing significantly to the understanding of the microbiome's impact on cancer treatment. She has received multiple awards including the American Society of Clinical Oncology Young Investigator Award and the Women Melanoma Award from the Society for Immunotherapy of Cancer. Dr. Elkrief is an active member of the Institut du cancer de Montréal and is dedicated to advancing microbiome therapies for melanoma treatment.
Centre hospitalier de l’Université de Montréal (CHUM) • Montreal, QC
Leads research on gut tumor microbiome and its impact on cancer immunotherapy.
Most programs require French B2 level; specific departments may require C1 or C2.